BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ta MH, Rao P, Korgaonkar M, Foster SF, Peduto A, Harris DC, Rangan GK. Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease. Physiol Rep. 2014;2:pii: e12196. [PMID: 25501440 DOI: 10.14814/phy2.12196] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Ishizuka EK, Filgueiras LR, Rios FJ, Serezani CH, Jancar S. PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages. Sci Rep 2016;6:32092. [PMID: 27554194 DOI: 10.1038/srep32092] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
2 Pereira BP, do Valle GT, Salles BCC, Costa KCM, Ângelo ML, Torres LHL, Novaes RD, Ruginsk SG, Tirapelli CR, de Araújo Paula FB, Ceron CS. Pyrrolidine dithiocarbamate reduces alloxan-induced kidney damage by decreasing nox4, inducible nitric oxide synthase, and metalloproteinase-2. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1899-910. [PMID: 32440769 DOI: 10.1007/s00210-020-01906-1] [Reference Citation Analysis]
3 Ta MH, Liuwantara D, Rangan GK. Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells. BMC Nephrol. 2015;16:212. [PMID: 26666710 DOI: 10.1186/s12882-015-0193-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 Delen O, Uz YH. Protective effect of pyrrolidine dithiocarbamate against methotrexate-induced testicular damage. Hum Exp Toxicol 2021;40:S164-77. [PMID: 34340576 DOI: 10.1177/09603271211035674] [Reference Citation Analysis]
5 Ta MHT, Schwensen KG, Liuwantara D, Huso DL, Watnick T, Rangan GK. Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats. World J Nephrol 2016; 5(4): 339-357 [PMID: 27458563 DOI: 10.5527/wjn.v5.i4.339] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
6 Wang R, Wang N, Tang J, Chen Y, Gao J. The safety and efficacy of MPR-CTU combined with precise intraoperative ultrasonography guided flexible ureteroscope in the treatment of renal cystic disease. Exp Ther Med 2018;15:283-7. [PMID: 29375688 DOI: 10.3892/etm.2017.5379] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Woo YM, Ko JY, Lee EJ. Validation of Effective Therapeutic Targets for ADPKD Using Animal Models. In: Park JH, Ahn C, editors. Cystogenesis. Singapore: Springer; 2016. pp. 71-84. [DOI: 10.1007/978-981-10-2041-4_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Oey O, Rao P, Luciuk M, Mannix C, Rogers NM, Sagar P, Wong A, Rangan G. Effect of dimethyl fumarate on renal disease progression in a genetic ortholog of nephronophthisis. Exp Biol Med (Maywood) 2018;243:428-36. [PMID: 29436846 DOI: 10.1177/1535370218759313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ta MH, Schwensen KG, Foster S, Korgaonkar M, Ozimek-Kulik JE, Phillips JK, Peduto A, Rangan GK. Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease. PLoS One 2016;11:e0164193. [PMID: 27723777 DOI: 10.1371/journal.pone.0164193] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 Quek KJ, Ameer OZ, Phillips JK. Amlodipine Improves Vessel Function and Remodeling in the Lewis Polycystic Kidney Rat Mesenteric Artery. Am J Hypertens 2020;33:634-43. [PMID: 32215654 DOI: 10.1093/ajh/hpaa054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lu CW, Lin Y, Lei YP, Wang L, He ZM, Xiong Y. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity. PLoS One 2017;12:e0179908. [PMID: 28715444 DOI: 10.1371/journal.pone.0179908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Erokwu BO, Anderson CE, Flask CA, Dell KM. Quantitative magnetic resonance imaging assessments of autosomal recessive polycystic kidney disease progression and response to therapy in an animal model. Pediatr Res 2018;83:1067-74. [DOI: 10.1038/pr.2018.24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]